Relfovetmab
Relfovetmab is an anti-NGF monoclonal antibody (mAb) [1].
Product Specifications
CAS Number
[2171034-70-9]
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/relfovetmab.html
Purity
99.88
Solubility
10 mM in DMSO
Smiles
[Relfovetmab]
Molecular Weight
(147.94 kDa)
References & Citations
[1]Liu Wenshe Ray, et al. Protease switch for dual targets chimeric antigen receptor T-cell therapy. Patent. WO2021087245.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
TNFRSF16/NGF Receptor/CD271
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15324314 1 Vial
Lentiviral human CAVIN1 shRNA (UAS) - Lentiviral human CAVIN1 shRNA (UAS, RFP) (25)
Ask
View Details 
MBS086772-01 48 Well
Sheep Transient Receptor Potential Cation Channel Subfamily A, Member 1 ELISA Kit
Ask
View Details 
MBS086772-02 96 Well
Sheep Transient Receptor Potential Cation Channel Subfamily A, Member 1 ELISA Kit
Ask
View Details MBS086772-03 5x 96 Well
Sheep Transient Receptor Potential Cation Channel Subfamily A, Member 1 ELISA Kit
Ask
View Details MBS086772-04 10x 96 Well
Sheep Transient Receptor Potential Cation Channel Subfamily A, Member 1 ELISA Kit
Ask
View Details